DCF — ATRIUM HEALTH ANSON
Enterprise Value: $6.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$6.4M
Enterprise Value
$1.3M
PV of Cash Flows
$5.2M
PV of Terminal Value
$8.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $24.5M | $1.2M | 5.0% | $0.0M | $0.0M |
| Year 2 | $25.3M | $1.5M | 6.0% | $0.2M | $0.2M |
| Year 3 | $26.0M | $1.8M | 7.0% | $0.4M | $0.3M |
| Year 4 | $26.8M | $2.0M | 7.0% | $0.5M | $0.4M |
| Year 5 | $27.6M | $2.1M | 8.0% | $0.6M | $0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $6.4M. Terminal value accounts for 80% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$23.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.044945027105259334
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5